ESC 365 - Generation and validation of a mouse model of the phospholamban p.Arg14del mutation

HFA Premium Access

Generation and validation of a mouse model of the phospholamban p.Arg14del mutation

Session: Young Investigator Award: Basic Science and Translational Science

Topic: Experimental Heart Failure

Speaker: Mr T. Eijgenraam (Groningen, NL)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Mr Tim Eijgenraam

University Medical Centre Groningen, Groningen (Netherlands (The))

0 follower

5 more presentations in this session

HDAC inhibitors repress cardiac hypertrophy through hyperacetylation of 14-3-3 chaperones and nuclear accumulation of class II HDACs

Speaker: Mr D. Finke (Heidelberg, DE)

Changes in titin phosphorylation and PKG activity underlie diastolic dysfunction at the cross-bridge level in the early stages of type 2 diabetes

Speaker: Doctor M. Waddingham (Suita, JP)

Myocyte BDNF generation prevents chronic post-ischemic decompensation via cardiac reinnervation: the role of beta-AR and GRK2 signals.

Speaker: Doctor A. Cannavo (Napoly, IT)

Desmosomal integrity is challenged by exercise-induced strain in iPSC-derived cardiomyocytes with a novel desmoplakin mutation

Speaker: Ms M. Vermeer (Groningen, NL)

The myocardial infarction context dictates the phenotypic polarisation of antigen-specific CD4+T-cells and favours pro-healing responses in the wounded myocardium

Speaker: Mr M. Rieckmann (Halle, DE)

Access the full session

Young Investigator Award: Basic Science and Translational Science

Speakers: Mr T. Eijgenraam, Mr D. Finke, Doctor M. Waddingham, Doctor A. Cannavo, Ms M. Vermeer...

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources